Go Freelance Jobs

Paul Mampilly does it Again

Profit Unlimited was recently tipped to be the leading newsletter in the financial world. The pundits seem to be right as the paper recently reached 60,000 subscribers. Among the people who write for this newsletter is Paul Mampilly who has an eight-page column to write about a stock investment he thinks will make the subscribers money. With his 20 years of experience in the financial world, he has made his readers millions of money. Investors who made decisions according to his advice have made profits worth 18 percent, 21 percent, 31 percent and 31 percent of their initial investments. In his latest tip about a semiconductor company in Silicon Valley, investors who followed his advice have now seen an 180 percent increase of their initial investment.

A subscriber who had made a profit of $45, 190 thanks to Paul Mampilly hailed him as one of the most experienced financial advisors in the United States. Paul gets a share of the profit that the Profits Unlimited makes from subscriptions. During his 20 years on Wall Street, Paul has worked with high profile companies such as Kinetics International, ING, and Deutsche Bank. He has also won several awards during this period that include an award by the Templeton Foundation. He won this award by transforming a $50 million investment to an $88 investment in a timed period. This was a 76 percent increase in the initial investment, and he termed it as a great achievement. Click here to know more.

Paul Mampilly is also active when it comes to philanthropy where he is involved with many causes. Some the causes that he has been involved with include Coalition for the Homeless, Inc., Big Brothers Big Sisters and International Center in New York. Not only does he dedicate his time to these institutions, but he also makes donations worth millions from time to time.

Google Plus: Plus.google.com/u/0/+PaulMampilly

PodcastOne Chairman Announces “Beyond the Darkness” Coming to Jericho Network

The Jericho Network is happily welcoming the new program “Beyond the Darkness” to its ranks. The show will be presented by Dave Schrader and Tim Dennis and will be insightful conversations with a diverse menagerie of guests who have personal experience with the paranormal and investigators of the supernatural. Points of discussion vary from simple neighborhood ghost stories to elaborate and strange alien encounters. Chris Jericho, the WWE star and proud leader of the Jericho Network, is excited to see this new concept and the new fans coming to his channel and allow it to evolve from its beginnings in wrestling. Norman Pattiz, Chairman of the company PodcastOne, informed the public in December 2016 that “Beyond the Darkness” will soon be available on the Jericho Network every Monday.

Norman Pattiz is a current Chairman with PodcastOne as well as the founder of the company. Already, PodcastOne and PodcastOne Sales are among the top in podcast marketing and sales, succeeding the line of profitable endeavors in Pattiz’ career. He began by founding Westwood One in 1974, America’s biggest radio network in broadcasting, then, while serving on the Broadcasting Board of Governors, the creation of Radio Sawa radio network, and finally by reaching the entirety of the Middle East with Alhurra Television. When he left Westwood One in 2010, he founded the Courtside Group and has also launched PodcastOne in June of last year.

Pattiz decided to enter the world of podcasting when Kit Gray, a Podcast Representative, helped Pattiz see the similarities between a podcast and a radio broadcast. Once that realization was made, he dived into his current venture and enjoys the new, yet similar, digital world of podcasting. He has discovered that the growth of PodcastOne has come from new ideas to stay fresh and alluring to consumers, who determine the success of a program almost instantaneously. This is very unlike his prior success in broadcasting, which came from the more technical aspects of the business and not completely on the content and consumers. The democracy of this new medium fascinates Pattiz and keeps him excited about his continuing legacy in the broadcasting and podcasting communities.

Read more: http://www.prnewswire.com/news-releases/president-clinton-names-norman-pattiz-as-member-of-the-broadcasting-board-of-governors-72895702.html

IT Staffing at its Best with John Goullet

John Goullet is a flourishing and a wealthy entrepreneur who majors mostly with IT staffing. He studied at Ursinus College accomplished masters in Computer Science. He started his career in IT by being an IT Consultant. He began his IT operating in the year 1994. He targeted higher goals because of his expertise growth every day therefore accomplishing a lot in IT industry. He is the main founder of Info Technologies whereby it’s the first company he started. The company provides IT staffing solutions to several firms in the universe. Info Technologies has assisted more than 500 firms and the companies have really benefited with the services which they were given.

Inc Magazine revealed that Info Technologies made$30 million within 5 years and is the leading private US Company that has rapidly advanced. This accomplishment is because of John Goullet better supervision. Diversant Inc is the company which Info Technologies linked with and therefore forming Diversant LLC. John Goullet is the principle of the company therefore his responsibility is to provide new strategies that will improve the business. The main objective of Diversant is bringing together workers of the company in order to advance on the enrichment of the company.

John Goullet together with his staff members always ensures that they have the optimistic mindset and have decent ethics so that they can improve the success of Diversant. Through this principal mostly in IT working surrounding contributes to better achievement. Some of other principal in that company should follow in order for them to constantly grow to include proficient cooperation and good moralities. John Goullet is very satisfied with the outcomes and also inspires his team to always work hard. Moreover Diversant is one of the top African-American businesses in the United States.

The company smaller certificate owned business is one of the achievements of the company. As well as in the finance sector made a lot of success therefore developing them to the top level. John Goullet is a joy full man because of the brilliant growth of the organization. Diversant has developed due to the dedication of the staff members.

 

 

Dr. Clay Siegall – Seattle Genetics leads cancer research

Clay Siegall is the President, CEO and Chairman of the Board for Seattle Genetics. He co-founded Seattle Genetics in 1998 with the goal of developing antibody drug conjugates (ADCs) for cancer treatment. ADCs are valuable in cancer treatment as they directly target cancer cells, while not affecting other healthy cells, thus avoiding some of the more debilitating effects of other cancer treatments such as chemotherapy.

 

Dr. Siegall is more than just a businessman, but a dedicated science with more than 20 years experience in cancer research including a PhD from George Washington University. Before co-founding Seattle Genetics Dr. Siegall worked with Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997 and the National Cancer Institute, National Institutes of Health from 1988 to 1991.

 

Under Dr. Siegall’s leadership Seattle Genetics gained approval from the FDA in 2011 to market the first commercially available ADC product ADCETRIS. Now, this treatment is available in 60 countries worldwide fighting cancer globally.

 

Seattle Genetics hold its mission as “Improving the lives of people with cancer through innovative and empowered antibody-based therapies” via more than 800 employees who work at the company. According to glassdoor.com 88% of employees approve of CEO Clay Siegall and Seattle Genetics received a 3.7 star rating as a company.

 

Future projects of Seattle Genetics include initiation of Phase 1 Trial of SGN-CD352A for Patients with Relapsed or Refractory Multiple Myeloma, a disease which affects more than 124,000 people world-wide. The phase 1 clinical study will enroll approximately 75 relapsed or refractory patients.